Miscellaneous
fromwww.theguardian.com
4 hours agoAstraZeneca CEO hails NHS drug price deal but keeps pause on 200m UK investment
AstraZeneca calls the UK-US drug pricing deal positive but says it is unlikely to restart the paused £200m Cambridge research investment.